Cita APA

Craft, C., Romero, D., Vary, C., & Bergan, R. (2007). Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway.

Chicago Style Citation

Craft, CS, D. Romero, CPH Vary, i RC Bergan. Endoglin Inhibits Prostate Cancer Motility Via Activation of the ALK2-Smad1 Pathway. 2007.

Cita MLA

Craft, CS, D. Romero, CPH Vary, i RC Bergan. Endoglin Inhibits Prostate Cancer Motility Via Activation of the ALK2-Smad1 Pathway. 2007.